c-Jun, JunB, and C/EBPβ promote glycolysis in melanoma cells through transcriptionally activate genes for glycolysis enzymes and consequentially weaken the anticancer effect of CD8+ T cells [34]. This evidence concerns the gene CEBPB and melanoma.